Ambiotis

Ambiotis is a pre-clinical CRO specialized in the study of inflammatory processes and the active end of inflammation, called resolution. Resolution is now recognized as the necessary biological process to stop inflammation and restore homeostasis in tissues. This recent approach makes possible to study the inflammation process in a completely innovative and differentiating way. Ambiotis proposes services adapted to pharmaceutical, dermo-cosmetic, agro- food/nutraceutical industries to evaluate the potential of their molecules at preclinical or clinical stages of development. Ambiotis thus helps them to put faster on the market more efficient and innovative compounds on immuno-inflammatory processes. With more than 10 years of experience, Ambiotis has acquired a solid expertise in understanding the molecular mechanisms controlling these phenomenons. Ambiotis has built a strong expertise in both cell/animal models and analytical measurement. This combination is the key to ensure a full understanding and provide proof of efficacy or proof of concept for the development of new innovative products.